Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Nakashima

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
International Journal of Hematology|September 28, 2019
Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patientsTakahiko Nakane, Hiroshi Okamura, Yumi Tagaito, et al.
Annals of Hematology|April 25, 2024
Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemiaKumiyo Tazoe, Naonori Harada, Yosuke Makuuchi, et al.
International Journal of Hematology|September 29, 2021
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantationHirohisa Nakamae, Takahiko Nakane, Hiroshi Okamura, et al.
Iscience|August 22, 2022
Identification of a drug-response gene in multiple myeloma through longitudinal single-cell transcriptome sequencingToru Masuda, Shojiro Haji, Yasuhiro Nakashima, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2025
Mogamulizumab Concentration-guided Allogeneic Transplantation and Successful Intrathecal Chemotherapy for Central Nervous System-relapsed Adult T-cell Leukemia/LymphomaSaki Fujii, Kazuki Sakatoku, Yosuke Nakaya, et al.
Transplant Immunology|January 7, 2024
Comparison of long-term outcomes after first HLA-mismatched unrelated donor transplantation with single unrelated cord blood transplantation using reduced-intensity or reduced-toxicity conditioningMasatomo Kuno, Hideo Koh, Kentaro Ido, et al.
Acta Haematologica|July 5, 2022
Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion CohortHiroaki Goto, Chitose Ogawa, Hiroatsu Iida, et al.
Cardiovascular Research|May 25, 2010
Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathwayTakahiro Horie, Koh Ono, Hitoo Nishi, et al.
Acta Haematologica|July 11, 2019
Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8Taisuke Narazaki, Motoaki Shiratsuchi, Mariko Tsuda, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2016
Plasma Kinetics of Th1, Th2 and Th17 Cytokines in Polymyositis Related to Chronic Graft-versus-Host DiseaseShiro Koh, Hideo Koh, Yasuhiro Nakashima, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
International Journal of Hematology|September 28, 2019
Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patientsTakahiko Nakane, Hiroshi Okamura, Yumi Tagaito, et al.
Annals of Hematology|April 25, 2024
Systemic inflammatory autoimmune disease before allogeneic hematopoietic stem cell transplantation is a risk factor for death in patients with myelodysplastic syndrome or chronic myelomonocytic leukemiaKumiyo Tazoe, Naonori Harada, Yosuke Makuuchi, et al.
International Journal of Hematology|September 29, 2021
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantationHirohisa Nakamae, Takahiko Nakane, Hiroshi Okamura, et al.
Iscience|August 22, 2022
Identification of a drug-response gene in multiple myeloma through longitudinal single-cell transcriptome sequencingToru Masuda, Shojiro Haji, Yasuhiro Nakashima, et al.
Internal Medicine (Tokyo, Japan)|October 22, 2025
Mogamulizumab Concentration-guided Allogeneic Transplantation and Successful Intrathecal Chemotherapy for Central Nervous System-relapsed Adult T-cell Leukemia/LymphomaSaki Fujii, Kazuki Sakatoku, Yosuke Nakaya, et al.
Transplant Immunology|January 7, 2024
Comparison of long-term outcomes after first HLA-mismatched unrelated donor transplantation with single unrelated cord blood transplantation using reduced-intensity or reduced-toxicity conditioningMasatomo Kuno, Hideo Koh, Kentaro Ido, et al.
Acta Haematologica|July 5, 2022
Safety and Efficacy of Blinatumomab in Japanese Adult and Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: Final Results from an Expansion CohortHiroaki Goto, Chitose Ogawa, Hiroatsu Iida, et al.
Cardiovascular Research|May 25, 2010
Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathwayTakahiro Horie, Koh Ono, Hitoo Nishi, et al.
Acta Haematologica|July 11, 2019
Intestinal Behçet's Disease with Primary Myelofibrosis Involving Trisomy 8Taisuke Narazaki, Motoaki Shiratsuchi, Mariko Tsuda, et al.
Internal Medicine (Tokyo, Japan)|August 16, 2016
Plasma Kinetics of Th1, Th2 and Th17 Cytokines in Polymyositis Related to Chronic Graft-versus-Host DiseaseShiro Koh, Hideo Koh, Yasuhiro Nakashima, et al.
Pageof 18